Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy

• Main Authors: Alexander Hendricks (Author), Philip Rosenstiel (Author), Sebastian Hinz (Author), Greta Burmeister (Author), Christoph Röcken (Author), Kathrin Boersch (Author), Clemens Schafmayer (Author), Thomas Becker (Author), Andre Franke (Author), Michael Forster (Author)
• Format: Book
• Published: BMC, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Liquid biopsies of blood plasma cell free DNA can be used to monitor treatment response and potentially detect mutations that are present in resistant clones in metastatic cancer patients. Case presentation In our non-interventional liquid biopsy study, a male patient in his fift...